Published in:
01-07-2003 | Commentary
Genes and pathways driving glioblastomas in humans and murine disease models
Author:
Karl Frei
Published in:
Neurosurgical Review
|
Issue 3/2003
Login to get access
Excerpt
This scholarly review describes characteristic genetic alterations that underlie the initiation and progression of glioblastomas in humans and rodent models. These alterations include the inactivation of tumor suppressor genes such as TP53, CDKN2A/p16, RB, and PTEN and activation of oncogenes including the epidermal growth factor receptor (EGFR), CDK4, CDK6, Ras, and Akt. …